Scholars Central

Conference abstractPublished 26 Jun 2017

Inhibition effects of Tarragon (Artemisia dracunculus L.) extracts and its metabolites against the Carbonic anhydrase I and II isozymes

Authors: Tuba Aydin, Bayram Yurtvermez, Ahmet Cakir, Murat Senturk, Caviz Kazaz

Agri Ibrahim Cecen University, Turkey Kilis 7 Aralik University, Turkey Ataturk University, Turkey

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Tarragon, Artemisia dracunculus L. is a small shrub and perennial plant species. It spreads in Japan, India, Iran, Europe, North America and China. The plant has several medicinal properties. It used in making vinegar and salad. In this study, five metabolites were isolated from dichloromethane extract from tarragon and their the chemical structure was characterized as anethole (1), Ã?²-stigmasterol (2), herniarin (3), (2E,4E)-N-isobutylundeca-2,4-dien-8,10-diynamide (4) and (2E,4E)-1- (piperidin-1-yl)undeca-2,4-diene-8,10-diyn-1-one (5) by IR, 1D and 2D NMR spectroscopic methods. Enzyme inhibition activities of ethanol, dichloromethane, n-hexane and methanol extracts of A. dracunculus L. and all of the pure metabolites were investigated against human carbonic anhydrase I and II isoenzymes. Enzyme inhibition effects of the extracts and pure metabolites were evaluated by comparison of their IC50 values for the first time in this study. Our results showed that the extracts and the pure compounds of A. dracunculus L. were found to be strong inhibitor against the human carbonic anhydrase I and II isoenzymes. The compounds and extracts were showed in the range of 8.65-486.2 Ã?¼M of IC50 values for Carbonic anhydrase I and II.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Pharmaceutical Regulatory Affairs: Open Access.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalPharmaceutical Regulatory Affairs: Open Access
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Tuba Aydin”
  • BylineArticles whose byline prints “Bayram Yurtvermez”
  • BylineArticles whose byline prints “Ahmet Cakir”
  • BylineArticles whose byline prints “Murat Senturk”
  • BylineArticles whose byline prints “Caviz Kazaz”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels